Lance De Barry
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lance De Barry has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Vishal Bahall
Department of Obstetrics and Gynaecology, San Fernando General Hospital, South-West Regional Health Authority, Trinidad and Tobago
14 shared publications- Vishal Bahall
Department of Obstetrics and Gynaecology, San Fernando General Hospital, South-West Regional Health Authority, Trinidad and Tobago
4 shared publications Keevan Singh
Department of Anaesthesia and Intensive Care, San Fernando General Hospital, South-West Regional Health Authority, San Fernando, Trinidad and Tobago
3 shared publications- Keevan Singh
Department of Anaesthetics and Intensive Care San Fernando General Hospital San Fernando Trinidad and Tobago
2 shared publications Mickhaiel Barrow
Pathology, Port of Spain General Hospital, Port-of-Spain, TTO
2 shared publicationsNadia Nidhan
Department of Obstetrics and Gynaecology, San Fernando General Hospital, South-West Regional Health Authority, Trinidad and Tobago
2 shared publications
Latest Publications
- Open Access
- 23 June 2026
- Published by Elsevier in Case Reports in Women's Health
- Vol. 51, e00836
A rare case of canal of Nuck cyst in a nulliparous woman of reproductive age: A case report and literature review
- 23 June 2026
- Published by Elsevier in Case Reports in Women's Health
- Vol. 51, e00836
Open AccessA rare case of canal of Nuck cyst in a nulliparous woman of reproductive age: A case report and literature review
- Open Access
- 1 May 2026
- Published by Elsevier in Case Reports in Women's Health
- Vol. 50, e00817
Primary ovarian leiomyosarcoma in a woman in her 70s: A case report
- 1 May 2026
- Published by Elsevier in Case Reports in Women's Health
- Vol. 50, e00817
Open AccessPrimary ovarian leiomyosarcoma in a woman in her 70s: A case report
- Open Access
- 24 March 2026
- Published by Elsevier in Case Reports in Women's Health
- Vol. 50, e00803
Squamous cell carcinoma arising within a mature cystic teratoma of the ovary in a postmenopausal woman: A case report and literature review
- 24 March 2026
- Published by Elsevier in Case Reports in Women's Health
- Vol. 50, e00803
Open AccessSquamous cell carcinoma arising within a mature cystic teratoma of the ovary in a postmenopausal woman: A case report and literature review
- Open Access
- 20 January 2026
- Published by Elsevier in Case Reports in Women's Health
- Vol. 49, e00786
Endometriosis beyond the pelvis: Insights from atypical presentations leading to diagnostic delays
- 20 January 2026
- Published by Elsevier in Case Reports in Women's Health
- Vol. 49, e00786
Open AccessEndometriosis beyond the pelvis: Insights from atypical presentations leading to diagnostic delays
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Anesthesiology
- Vol. 2026 (1) , 5784668
Cold‐Induced Symptoms in a Young Female: A Perioperative Case of Cold Urticaria for Gynecologic Surgery—A Case Report
Background: Cold urticaria is a rare subtype of chronic inducible urticaria that is associated with the development of localized or systemic symptoms following exposure to cold stimuli. Although considered benign, it may be associated with severe reactions, including anaphylactoid reactions. This can occur upon direct or indirect exposure to cold temperatures, liquids, and objects. The perioperative environment contains multiple potential cold triggers which can cause generalized hypersensitivity reactions in these patients. Little is known of the perioperative course and management of these patients, and there are few reported cases. Treatment of cold urticaria involves the use of antihistamine medication and avoidance of cold triggers. Case Presentation: We describe the case of a young female with undiagnosed cold urticaria that was detected shortly before surgery. A detailed history revealed recurrent cold‐induced symptoms, including a prior episode suggestive of airway compromise. A presumptive diagnosis was made based on clinical history and later confirmed with a cold stimulation test. Perioperative management was modified to minimize cold exposure and include prophylactic antihistamine and corticosteroid therapy. Despite these measures, localized urticarial changes occurred intraoperatively following exposure to cold antiseptic solution on the abdomen without progression to systemic manifestations. The patient remained hemodynamically stable throughout and had an uneventful postoperative recovery. Conclusion: This case highlights the importance of early recognition of cold urticaria and the implementation of targeted perioperative strategies to reduce the risk of adverse events. Currently, there are no standardized perioperative guidelines for cold urticaria, and given that patients may not spontaneously report cold‐induced symptoms, specific screening questions during preoperative assessment should be considered to improve detection and optimize perioperative safety.
- 1 January 2026
- Published by Wiley in Case Reports in Anesthesiology
- Vol. 2026 (1) , 5784668
Open AccessCold‐Induced Symptoms in a Young Female: A Perioperative Case of Cold Urticaria for Gynecologic Surgery—A Case Report
Background: Cold urticaria is a rare subtype of chronic inducible urticaria that is associated with the development of localized or systemic symptoms following exposure to cold stimuli. Although considered benign, it may be associated with severe reactions, including anaphylactoid reactions. This can occur upon direct or indirect exposure to cold temperatures, liquids, and objects. The perioperative environment contains multiple potential cold triggers which can cause generalized hypersensitivity reactions in these patients. Little is known of the perioperative course and management of these patients, and there are few reported cases. Treatment of cold urticaria involves the use of antihistamine medication and avoidance of cold triggers. Case Presentation: We describe the case of a young female with undiagnosed cold urticaria that was detected shortly before surgery. A detailed history revealed recurrent cold‐induced symptoms, including a prior episode suggestive of airway compromise. A presumptive diagnosis was made based on clinical history and later confirmed with a cold stimulation test. Perioperative management was modified to minimize cold exposure and include prophylactic antihistamine and corticosteroid therapy. Despite these measures, localized urticarial changes occurred intraoperatively following exposure to cold antiseptic solution on the abdomen without progression to systemic manifestations. The patient remained hemodynamically stable throughout and had an uneventful postoperative recovery. Conclusion: This case highlights the importance of early recognition of cold urticaria and the implementation of targeted perioperative strategies to reduce the risk of adverse events. Currently, there are no standardized perioperative guidelines for cold urticaria, and given that patients may not spontaneously report cold‐induced symptoms, specific screening questions during preoperative assessment should be considered to improve detection and optimize perioperative safety.
- Open Access
- 20 November 2025
- Published by Elsevier in Case Reports in Women's Health
- Vol. 48
Vaginal polypoid endometriosis in a woman in her 30s with advanced pelvic endometriosis: A case report and literature review
- 20 November 2025
- Published by Elsevier in Case Reports in Women's Health
- Vol. 48
Open AccessVaginal polypoid endometriosis in a woman in her 30s with advanced pelvic endometriosis: A case report and literature review
- Open Access
- 1 November 2025
- Published by Springer Nature in Cureus
- Vol. 17 (11)
Primary Small-Cell Neuroendocrine Carcinoma of the Vagina: A Case Report and Literature Review
Small-cell neuroendocrine carcinoma (SCNC) of the vagina is an exceedingly rare and highly aggressive tumor of the female genital tract. The vast majority of SCNCs occur outside the female genital tract, with gynecological involvement being remarkably rare. Despite modern advances in tumor genomic profiling, SCNC continues to demonstrate an aggressive clinical course and remains associated with an unfavorable prognosis. A 63-year-old woman presented to the Gynecology clinic with postmenopausal bleeding following a total abdominal hysterectomy with right salpingo-oophorectomy for uterine fibroids and a benign right ovarian cyst several years before. On assessment, a vaginal wall mass was discovered, and subsequent biopsy with histopathological assessment demonstrated an SCNC. Positron-emission tomography computed tomography confirmed primary vaginal SCNC with no metastatic foci. The patient subsequently underwent localized excision and was recommended for systemic treatment after a multidisciplinary team discussion. Following the first reported case many years ago, only a small number of cases have been documented in the medical literature. Due to the paucity of publications on SCNC of the vagina, there is currently no consensus on standard treatment protocols for this tumor. Therefore, we aim to raise awareness and research on this unique presentation of SCNC of the vagina.
- 1 November 2025
- Published by Springer Nature in Cureus
- Vol. 17 (11)
Open AccessPrimary Small-Cell Neuroendocrine Carcinoma of the Vagina: A Case Report and Literature Review
Small-cell neuroendocrine carcinoma (SCNC) of the vagina is an exceedingly rare and highly aggressive tumor of the female genital tract. The vast majority of SCNCs occur outside the female genital tract, with gynecological involvement being remarkably rare. Despite modern advances in tumor genomic profiling, SCNC continues to demonstrate an aggressive clinical course and remains associated with an unfavorable prognosis. A 63-year-old woman presented to the Gynecology clinic with postmenopausal bleeding following a total abdominal hysterectomy with right salpingo-oophorectomy for uterine fibroids and a benign right ovarian cyst several years before. On assessment, a vaginal wall mass was discovered, and subsequent biopsy with histopathological assessment demonstrated an SCNC. Positron-emission tomography computed tomography confirmed primary vaginal SCNC with no metastatic foci. The patient subsequently underwent localized excision and was recommended for systemic treatment after a multidisciplinary team discussion. Following the first reported case many years ago, only a small number of cases have been documented in the medical literature. Due to the paucity of publications on SCNC of the vagina, there is currently no consensus on standard treatment protocols for this tumor. Therefore, we aim to raise awareness and research on this unique presentation of SCNC of the vagina.
- Open Access
- 22 August 2025
- Published by Elsevier in Case Reports in Women's Health
- Vol. 47, e00745
Laparoscopic management of a heterotopic cornual pregnancy following first-trimester miscarriage – A case report and literature review
- 22 August 2025
- Published by Elsevier in Case Reports in Women's Health
- Vol. 47, e00745
Open AccessLaparoscopic management of a heterotopic cornual pregnancy following first-trimester miscarriage – A case report and literature review
- Open Access
- 21 April 2025
- Published by SAGE Publications in Women's Health
- Vol. 21
Day case total laparoscopic hysterectomy in a low resource setting: A descriptive analysis
Background: A laparoscopic approach to hysterectomy can significantly reduce patient morbidity and improve the quality of recovery. Subsequent perioperative advances have led to an increasingly shorter hospitalization period following laparoscopic surgery, with the same-day discharge being common. However, due to infrastructural challenges, these shorter times to discharge have mostly been limited to developed countries. Objectives: To provide a descriptive analysis and evaluate the safety and feasibility of day-case laparoscopic hysterectomy in Trinidad and Tobago. Design: A retrospective analysis of all total laparoscopic hysterectomies over a 3-year period at a secondary medical center in Trinidad and Tobago. Methods: The medical records of 154 women who underwent total laparoscopic hysterectomy (TLH) from January 2020 to January 2023 were reviewed. Patient demographics, indications for surgery, perioperative variables, requirements for any additional operative procedures, and perioperative complications were recorded and analyzed. The perioperative management protocol was also outlined. Results: The most common indication for TLH was uterine leiomyoma (45%), followed by endometrial cancer (17.5%). In this study, 96% of patients were discharged satisfactorily within 24 h of surgery, and the mean ± standard deviation (SD) duration of hospitalization was 21 ± 2 h. The mean ± SD surgical time was 91 ± 36 min, and the average estimated blood loss was 93 ± 31 ml. No patients required postoperative blood transfusion. No postoperative opioids were required in 41% of patients, and no perioperative mortality was recorded in this study, with no patients requiring re-operation. Four postoperative complications were noted (2.6%), and this included two patients who developed deep vein thrombosis (DVT) (1.3%), one port-site infection (0.6%), and one case of pulmonary embolism (0.6%). The 30-day readmission rate was 1.9%, and this comprised the patients with DVT and pulmonary embolism. On subgroup analysis, there was no difference in surgical time between patients with body mass index >30 kg/m 2 , uterine size >12 weeks, and previous abdominal surgery ( p > 0.05). Conclusion: Day-case laparoscopic hysterectomy is feasible in a low-resource setting like Trinidad and Tobago. The procedure is safe and associated with a low postoperative complication rate.
- 21 April 2025
- Published by SAGE Publications in Women's Health
- Vol. 21
Open AccessDay case total laparoscopic hysterectomy in a low resource setting: A descriptive analysis
Background: A laparoscopic approach to hysterectomy can significantly reduce patient morbidity and improve the quality of recovery. Subsequent perioperative advances have led to an increasingly shorter hospitalization period following laparoscopic surgery, with the same-day discharge being common. However, due to infrastructural challenges, these shorter times to discharge have mostly been limited to developed countries. Objectives: To provide a descriptive analysis and evaluate the safety and feasibility of day-case laparoscopic hysterectomy in Trinidad and Tobago. Design: A retrospective analysis of all total laparoscopic hysterectomies over a 3-year period at a secondary medical center in Trinidad and Tobago. Methods: The medical records of 154 women who underwent total laparoscopic hysterectomy (TLH) from January 2020 to January 2023 were reviewed. Patient demographics, indications for surgery, perioperative variables, requirements for any additional operative procedures, and perioperative complications were recorded and analyzed. The perioperative management protocol was also outlined. Results: The most common indication for TLH was uterine leiomyoma (45%), followed by endometrial cancer (17.5%). In this study, 96% of patients were discharged satisfactorily within 24 h of surgery, and the mean ± standard deviation (SD) duration of hospitalization was 21 ± 2 h. The mean ± SD surgical time was 91 ± 36 min, and the average estimated blood loss was 93 ± 31 ml. No patients required postoperative blood transfusion. No postoperative opioids were required in 41% of patients, and no perioperative mortality was recorded in this study, with no patients requiring re-operation. Four postoperative complications were noted (2.6%), and this included two patients who developed deep vein thrombosis (DVT) (1.3%), one port-site infection (0.6%), and one case of pulmonary embolism (0.6%). The 30-day readmission rate was 1.9%, and this comprised the patients with DVT and pulmonary embolism. On subgroup analysis, there was no difference in surgical time between patients with body mass index >30 kg/m 2 , uterine size >12 weeks, and previous abdominal surgery ( p > 0.05). Conclusion: Day-case laparoscopic hysterectomy is feasible in a low-resource setting like Trinidad and Tobago. The procedure is safe and associated with a low postoperative complication rate.
- Open Access
- 2 February 2025
- Published by Springer Nature in Cureus
- Vol. 17 (2) , e78389
A Pilot Study on the Feasibility and Integration of High-Risk Human Papillomavirus (HPV) Testing for Cervical Cancer Prevention in Trinidad and Tobago
Background Globally, cervical cancer is one of the leading causes of cancer-related death among women. Persistent infection with high-risk human papillomavirus (hrHPV) is the predominant etiological factor for cervical cancer, underscoring the critical need for effective screening to enable early detection and reduce disease burden. However, in Trinidad and Tobago, liquid-based cytology is not available in the public healthcare system, and current screening efforts rely solely on conventional Pap smears. This limitation restricts the integration of hrHPV testing either as a standalone primary screening tool or as part of a co-testing strategy. Addressing these gaps through infrastructure investment and policy reform is essential for achieving comprehensive and equitable cervical cancer prevention. Objectives This study aimed to evaluate the feasibility of hrHPV testing within the public healthcare system of Trinidad and Tobago, identifying potential facilitators and barriers to nationwide implementation. Methods A descriptive cross-sectional study design was employed. Women aged 30-65 meeting specific inclusion criteria were recruited from 18 primary healthcare centers and a mobile unit between March 2019 and November 2019. HPV samples were collected, analyzed using the careHPV system, and categorized as positive or negative for high-risk HPV types. Patients with positive results underwent follow-up conventional cytology, with colposcopy referral as indicated by cytological findings. Results Out of 1241 women tested, 1201 were eligible. hrHPV positivity was detected in 140 women (11.7%), with the highest positivity rate observed in 75 women (15.7%) out of a cohort of 476 women in their 30s. Of those with positive results, 115 women (81.6%) were referred for cytology, revealing 12 cases of high-grade squamous intraepithelial lesions and a CIN 2/3 incidence of 46.7% (14 cases) among 30 women with concurrent positive HPV and abnormal cytology. Active call-and-recall mechanisms led to increased screening uptake by 33% within the target catchment area. Conclusion hrHPV testing demonstrated practical feasibility and improved sensitivity for detecting pre-invasive cervical lesions compared to cytology alone. Implementing a screening algorithm integrating HPV and cytology testing could optimize patient triage, alleviate colposcopy service demand, and enhance screening coverage. When combined with effective HPV vaccination campaigns, these measures present a viable path toward achieving the World Health Organization's cervical cancer elimination goals in Trinidad and Tobago.
- 2 February 2025
- Published by Springer Nature in Cureus
- Vol. 17 (2) , e78389
Open AccessA Pilot Study on the Feasibility and Integration of High-Risk Human Papillomavirus (HPV) Testing for Cervical Cancer Prevention in Trinidad and Tobago
Background Globally, cervical cancer is one of the leading causes of cancer-related death among women. Persistent infection with high-risk human papillomavirus (hrHPV) is the predominant etiological factor for cervical cancer, underscoring the critical need for effective screening to enable early detection and reduce disease burden. However, in Trinidad and Tobago, liquid-based cytology is not available in the public healthcare system, and current screening efforts rely solely on conventional Pap smears. This limitation restricts the integration of hrHPV testing either as a standalone primary screening tool or as part of a co-testing strategy. Addressing these gaps through infrastructure investment and policy reform is essential for achieving comprehensive and equitable cervical cancer prevention. Objectives This study aimed to evaluate the feasibility of hrHPV testing within the public healthcare system of Trinidad and Tobago, identifying potential facilitators and barriers to nationwide implementation. Methods A descriptive cross-sectional study design was employed. Women aged 30-65 meeting specific inclusion criteria were recruited from 18 primary healthcare centers and a mobile unit between March 2019 and November 2019. HPV samples were collected, analyzed using the careHPV system, and categorized as positive or negative for high-risk HPV types. Patients with positive results underwent follow-up conventional cytology, with colposcopy referral as indicated by cytological findings. Results Out of 1241 women tested, 1201 were eligible. hrHPV positivity was detected in 140 women (11.7%), with the highest positivity rate observed in 75 women (15.7%) out of a cohort of 476 women in their 30s. Of those with positive results, 115 women (81.6%) were referred for cytology, revealing 12 cases of high-grade squamous intraepithelial lesions and a CIN 2/3 incidence of 46.7% (14 cases) among 30 women with concurrent positive HPV and abnormal cytology. Active call-and-recall mechanisms led to increased screening uptake by 33% within the target catchment area. Conclusion hrHPV testing demonstrated practical feasibility and improved sensitivity for detecting pre-invasive cervical lesions compared to cytology alone. Implementing a screening algorithm integrating HPV and cytology testing could optimize patient triage, alleviate colposcopy service demand, and enhance screening coverage. When combined with effective HPV vaccination campaigns, these measures present a viable path toward achieving the World Health Organization's cervical cancer elimination goals in Trinidad and Tobago.